Effective execution of health services and sustainability of public health is possible with the
strength of the pharmaceutical industry. The pharmaceutical sector, which has a high added
value thanks to continuously increasing R&D activities, also makes a great contribution to
economic development. Turkey;s position in the sector is of strategic importance due to its
advanced technology, production experience based on long experience and export opportunities.
While Turkey imports pharmaceuticals like many developed countries, it also exports to many
countries as a wholesaler.
General Situation of the Pharmaceutical Industry
Many factors such as demographic changes, increase in life expectancy, structural changes in
diseases, pandemics, globalising world increase the need for the pharmaceutical sector.
Increasing accessibility in healthcare services and technological developments, as well as
increasing import and export figures, have made the pharmaceutical industry one of the largest
sectors.
In the global economy, the pharmaceutical sector is the sector with the highest R expenditure
due to its high cost and long-term studies. These expenditures increase regularly every year.
Thanks to the dynamic structure of the market, prescription and OTC drugs are of great
importance in international trade. The rate of increase in exports is high compared to previous
years due to the pandemic. As of 2020, Germany was the largest import country for the
pharmaceutical industry worldwide. In exports, the United States and South Korea take the first
places. In addition to Asian countries, there are also export markets with high potential in Europe,
America, the Middle East and Africa.
General Status of the Sector in the Turkish Market
Turkey is one of the countries with a production capacity and technology comparable to European
countries. Like many countries with high production capacity, Turkey imports medicines that are
under protection and require advanced technology for their production. These medicines are
imported because they are not produced outside certain pharmaceutical centres. The imported
medicines include pharmaceuticals with high production costs in our country and medicines that
are less needed.
The share of the pharmaceuticals and pharmaceuticals sector in overall exports exceeded 1% for
the first time in 2020, reaching USD 1.8 billion. This growth corresponds to a growth of 26.8%
compared to the previous year. According to TUIK data, the largest share of the growth in exports
was taken by South Korea, followed by Iraq. These countries are followed by Kazakhstan,
Uzbekistan and Azerbaijan. The increase in imports was realised as 1.1%. As in exports, the first
ranking product group in imports was medicines used in treatment and protection. The country
ranking first in imports is Germany.
Especially during the pandemic, supply, logistics and customer problems, which are the
components of the pharmaceutical industry, were experienced in our country as in the whole
world. The stagnation in production, quarantine periods and measures taken due to the pandemic
caused an increase in raw material prices. Following the global pandemic, the strategic
importance of the pharmaceutical industry was revealed and strong steps were taken in domestic
production.
The most important issue in exports is to meet the demands and logistics needs of customers
that constitute international trade. There are many products subject to export such as prescription
and OTC products, medical devices, dietary products and vaccines. Among these products, it is
of great importance that cold chain medicines are stored in appropriate conditions and sent
reliably.
Sina Pharmaceutical Warehouse provides reliable storage conditions in accordance with the
regulations. It manages export processes both to local pharmacies and hospitals and abroad with
safe and fast shipping options. Sina Pharmaceutical Warehouse, which has a structure that can
respond quickly to all needs, also realises a significant part of the exports from our country.
Comments